MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 10-14-2025
Biomerica ROA Ratio 2011-2025 | BMRA
Annual ROA Ratio Biomerica
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -83.65 | -64.6 | -49.4 | -39.84 | -63.0 | -13.55 | -45.62 | -28.07 | -18.11 | -26.19 | -5.41 | -3.33 | 8.4 | 9.84 | 3.18 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 9.84 | -83.65 | -27.96 |
Quarterly ROA Ratio Biomerica
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -44.57 | -45.55 | -64.1 | -66.87 | -66.55 | -39.85 | -59.94 | -61.5 | -65.17 | -55.26 | -87.77 | -68.27 | -59.45 | -54.1 | -44.16 | -61.54 | -65.81 | -64.32 | -50.36 | -41.94 | -36.96 | -32.59 | -33.23 | -33.33 | -35.22 | -36.96 | -36.85 | -35.84 | -32.61 | -27.56 | -23.78 | -19.26 | -17.33 | -14.1 | -12.29 | -9.13 | -6.62 | -6.83 | -4.37 | -4.59 | -7.48 | -9.91 | -12.5 | -14.71 | -14.87 | -13.95 | -14.07 | -13.31 | -5.22 | 2.36 | 10.42 | 18.28 | 18.21 | 15.7 | 15.39 | 12.53 | 2.37 | 3.94 | 2.38 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 18.28 | -87.77 | -27.64 |
ROA Ratio of other stocks in the Diagnostics research industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-51.41 | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
-8.88 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
-22.47 | - | -61.36 % | $ 2.46 M |  USA |
 |
Brainsway Ltd.
BWAY
|
-8.53 | $ 19.06 | -1.6 % | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
-34.96 | $ 20.31 | -5.8 % | $ 221 M |  China |
 |
Co-Diagnostics
CODX
|
-37.07 | $ 0.23 | -4.17 % | $ 6.75 M | USA |
 |
Biocept
BIOC
|
-103.93 | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
-37.2 | - | 0.22 % | $ 16.8 M | USA |
 |
Castle Biosciences
CSTL
|
3.43 | $ 39.2 | -0.49 % | $ 1.09 B | USA |
 |
Danaher Corporation
DHR
|
5.03 | $ 230.87 | 0.23 % | $ 169 B | USA |
 |
DarioHealth Corp.
DRIO
|
-61.65 | $ 10.36 | 3.19 % | $ 294 M | Israel |
 |
BioNano Genomics
BNGO
|
-146.1 | $ 1.51 | -0.9 % | $ 1.92 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.77 | - | - | $ 562 M |  Britain |
 |
Exact Sciences Corporation
EXAS
|
-14.58 | $ 101.86 | 0.28 % | $ 18.9 B | USA |
 |
DexCom
DXCM
|
8.64 | $ 67.65 | 0.12 % | $ 26.1 B | USA |
 |
Enzo Biochem
ENZ
|
-30.41 | - | -8.98 % | $ 14.8 K | USA |
 |
Fulgent Genetics
FLGT
|
-3.5 | $ 26.63 | -0.34 % | $ 805 M | USA |
 |
Global Cord Blood Corporation
CO
|
5.87 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-16.33 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-34.28 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-33.12 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
-82.74 | - | -11.32 % | $ 2.94 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
4.72 | - | - | $ 10.7 B | USA |
 |
CareDx, Inc
CDNA
|
-40.76 | $ 19.19 | -1.49 % | $ 1.03 B | USA |
 |
Celcuity
CELC
|
-45.6 | $ 101.0 | -1.22 % | $ 3.98 B | USA |
 |
Heska Corporation
HSKA
|
-3.4 | - | - | $ 1.31 B | USA |
 |
Anixa Biosciences
ANIX
|
-58.14 | $ 3.19 | -0.31 % | $ 102 K | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-121.47 | - | -20.0 % | $ 1.06 M | USA |
 |
IQVIA Holdings
IQV
|
5.1 | $ 227.26 | 0.15 % | $ 41.2 B | USA |
 |
Guardant Health
GH
|
-29.37 | $ 100.93 | -1.99 % | $ 12.4 B | USA |
 |
Aspira Women's Health
AWH
|
-156.39 | - | -6.19 % | $ 10.5 M | USA |
 |
Myriad Genetics
MYGN
|
-12.39 | $ 6.32 | -2.55 % | $ 573 M | USA |
 |
ENDRA Life Sciences
NDRA
|
-258.47 | $ 4.75 | -4.81 % | $ 2.55 M | USA |
 |
Neogen Corporation
NEOG
|
-31.71 | $ 7.2 | 0.98 % | $ 1.56 B | USA |
 |
National Research Corporation
NRC
|
25.3 | $ 18.95 | 1.55 % | $ 465 M | USA |
 |
Illumina
ILMN
|
-19.4 | $ 134.56 | -0.29 % | $ 21.4 B | USA |
 |
Charles River Laboratories International
CRL
|
0.29 | $ 203.33 | -0.11 % | $ 10.4 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
5.39 | $ 175.36 | -0.34 % | $ 19.5 B | USA |
|
Biodesix
BDSX
|
-44.15 | $ 6.79 | -0.44 % | $ 880 M | USA |
 |
Motus GI Holdings
MOTS
|
-178.14 | - | -34.28 % | $ 263 K | Israel |
 |
Koninklijke Philips N.V.
PHG
|
10.73 | $ 27.26 | 0.57 % | $ 20 B |  Niderland |
 |
Laboratory Corporation of America Holdings
LH
|
4.06 | $ 252.95 | -0.4 % | $ 21.2 B | USA |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 182.75 | -0.05 % | $ 15.1 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
26.96 | $ 685.99 | -0.36 % | $ 56.6 B | USA |
 |
Lantheus Holdings
LNTH
|
15.78 | $ 67.0 | 0.43 % | $ 4.64 B | USA |
 |
Personalis
PSNL
|
-30.08 | $ 8.01 | -1.6 % | $ 475 M | USA |
 |
Mettler-Toledo International
MTD
|
26.64 | $ 1 419.41 | -0.06 % | $ 30.1 B |  Schweiz |
 |
Agilent Technologies
A
|
11.3 | $ 138.09 | -0.22 % | $ 42 B | USA |
 |
Quidel Corporation
QDEL
|
43.3 | $ 29.27 | -0.12 % | $ 1.23 B | USA |